Cancer Therapeutics has access to three established HTS facilities in Australia, taking advantage of their 30-plus years of combined operating experience. These facilities specialise in developing and miniaturising molecular, cell based and high content assays and together have prosecuted more than 100 HTS campaigns, many in collaboration with large pharmaceutical companies.

Cancer Therapeutics uses a purpose-built compound management facility with state of the art storage equipment and dispensing technology.

Cancer Therapeutics also draws on proven fragment screening expertise to identify high quality starting points for our medicinal chemists.

Hendrik Falk, High-Throughput Chemical Screening Lab, Chemical Biology 
Job number: 100132